See if PrEP for WINGS helps with starting and sticking to PrEP among women in community supervision programs
Official title: An Effectiveness Trial of WINGS+PrEP: a Syndemic mHealth Intervention to Increase PrEP Uptake Among Women Impacted by Heavy Alcohol Use and Partner Violence in the Criminal Legal System
Run by Columbia University · NCT06853314 · Data updated 2026-11-12
This study tests PrEP for WINGS plus PrEP compared with PrEP alone to see if it increases PrEP initiation and adherence among cisgender women in CSPs who use alcohol hazardously and may face IPV and HIV risk.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 307 (estimated) |
| Sponsor | Columbia University Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | April 9, 2026 |
| Main results expected | June 1, 2027 |
| Study ends | June 1, 2027 |
| Registry record updated | June 22, 2026 |
| Trial ID | NCT06853314 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Cisgender women aged 18 or older who have prior engagement with the criminal legal system or child protective services, report hazardous alcohol use, recent IPV, and recent HIV risk exposure, and are HIV-negative.
✕Probably not a fit
Individuals who do not use PrEP or do not pursue HIV risk-reducing behaviors may experience little to no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a hybrid Type 1 effectiveness and implementation trial conducted in New York City to evaluate an m-Health syndemic intervention that combines PrEP for WINGS with a PrEP decision aid. The study will measure initiation and adherence to PrEP over six months using self-reports and medical records, and will also examine changes in intimate partner violence, hazardous drinking, recidivism, and HIV risk. Subgroup analyses will explore moderation by race/ethnicity, sexual orientation, age, education, incarceration history, IPV severity, substance use disorders, digital access, housing stability, and medical mistrust. The trial targets cisgender women in community supervision programs, including probation, parole, and ATI settings, who report hazardous drinking and HIV risk exposure. Eligible settings include CSPs in NYC, with Columbia University as lead sponsor and NIH/NIAAA collaborators.
Why it matters
Potential benefit: If successful, the approach could increase PrEP uptake and adherence among women in CSPs, potentially reducing HIV risk and related health disparities.
How similar studies have gone: Previous mixed-methods PrEP interventions have shown promise in increasing uptake, but few have targeted women in CSPs or integrated m-Health supports for this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Identify as a cis-gender woman Aged 18 or older HIV-negative Previous engagement with the criminal legal system or child protective services. Meet criteria for hazardous alcohol use Previous experience of intimate partner veiolence Report not taking PrEP in the past 90 days Recent experiences of HIV risk due to HIV risk exposure Exclusion Criteria: Ability to speak and understand English is not sufficient to participate in assessments or intervention sessions. Inability to complete informed consent process due to a psychiatric or cognitive impairment (assessed by the Mini Folstein exam)
Where it's running
-
The Columbia Community Partnership for Health
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Anindita Dasgupta, MPH, PhD — Columbia University
- Study coordinator: Anindita Dasgupta, MPH, PhD
- Email: ad3341@cumc.columbia.edu
- Phone: 646-808-4861
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Reducing alcohol use and improving HIV treatment for men in fishing communities
This study is testing a new program to help men with HIV in fishing communities cut down on drinking and stick to their HIV treatment to improve their health.
-
Reducing alcohol use in PrEP users through SBIRT intervention
This study is testing if a program that helps people cut down on drinking can improve the health of those using PrEP for HIV prevention and help them stick to their medication.
-
Using a mobile app to reduce risky alcohol use and HIV risk
This study is testing a mobile app that sends real-time messages to help people reduce risky drinking and lower their chances of HIV by encouraging safer choices when they visit certain locations.
-
Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures
This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.
-
Thiamine to reduce brain injury in adults with alcohol use disorder
This trial tests whether thiamine can help protect the brain in adults with moderate to severe alcohol use disorder who drink daily.
-
Camino HIV Prevention and Care Study
This study tests a combined legal and peer-support program to help Latin American adults in DC and the Bay Area improve HIV testing, PrEP use, and care engagement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.